Dovetail Genomics Secures $2M SBIR Grant to Develop High-Throughput LinkPrep™ Solutions for Oncology Applications
Summary
Funding for the grant, titled Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types, will support additional development and validation of Dovetails recently launched LinkPrep technology in clinically relevant oncology sample types using an automated protocol and high-throughput analysis capabilities.We are thrilled about this award. We look forward to leveraging this grant to develop high-throughput capabilities and validate additional sample types, including FFPE, to drive broader utilization in oncology research.This announcement, coinciding with the American Society of Human Genetics (ASHG) 2024 conference, follows closely on the heels of the broad commercial launch of LinkPrep technology for somatic variant detection. Attendees can learn more at Booth #1148 and are encouraged to join the session Improved Somatic Variation Detection with Short Reads Using LinkPrep Technology on November 7th at 12:45pm in Theater 2. The session will feature presentations by Dr. Brian Walker, exploring sensitive structural variant discovery, and Dr. Cory Padilla, discussing the broad scope of somatic variant detection using LinkPrep technology.For more details on LinkPrep technology and other innovative solutions from Dovetail Genomics, please visit www.dovetailgenomics.com. Researchers are using Dovetail Genomics unique methods to solve complex problems including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, and microbiome analysis in the fields of epigenetics, developmental biology, cancer research, evolutionary biology and more.